Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
Phase 2
Completed
- Conditions
- Hyperlipidemias
- Interventions
- First Posted Date
- 2008-12-23
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 213
- Registration Number
- NCT00813527
An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2243
- Registration Number
- NCT00790933
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 366
- Registration Number
- NCT00787254
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2010-06-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 80
- Registration Number
- NCT00776074
Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2010-06-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 22
- Registration Number
- NCT00775840
Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
Phase 4
Completed
- Conditions
- ObesityHypertension
- Interventions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2012-08-08
- Lead Sponsor
- Takeda
- Target Recruit Count
- 188
- Registration Number
- NCT00775814
Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
Phase 3
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2010-07-05
- Lead Sponsor
- Takeda
- Target Recruit Count
- 418
- Registration Number
- NCT00772174
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
Phase 4
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Takeda
- Target Recruit Count
- 39
- Registration Number
- NCT00770835
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
Phase 3
Completed
- Conditions
- Diabetes MellitusDyslipidemias
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2010-10-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 305
- Registration Number
- NCT00770653
Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2010-09-01
- Lead Sponsor
- Takeda
- Target Recruit Count
- 40
- Registration Number
- NCT00770640
© Copyright 2025. All Rights Reserved by MedPath